Literature DB >> 19242511

Key role of macrophages in the pathogenesis of CD18 hypomorphic murine model of psoriasis.

Honglin Wang1, Thorsten Peters, Anca Sindrilaru, Karin Scharffetter-Kochanek.   

Abstract

Psoriasis is a chronic skin disorder of unsolved pathogenesis affecting skin in 2-3% of the general population. Research into the pathogenesis of psoriasis has profited from suitable animal models. Previously, we reported on the CD18 hypomorphic (CD18(hypo)) PL/J mouse model clinically resembling human psoriasis, which is characterized by reduced expression of the common chain of beta(2)-integrins (CD11/CD18) to only 2-16% of wild-type levels. Aside from common clinical and pathophysiological features shared with human psoriasis, the psoriasiform skin disease in CD18(hypo) PL/J mice also depends on the presence of CD4(+) T-cells. This review focuses on the role of activated macrophages in the pathogenesis of CD18(hypo) T-cell-mediated mouse model of psoriasis, and extends our understanding in unrestrained pathogenic T-cells whose activation may be crucial for the recruitment and activation of macrophages within skin. The findings in the CD18(hypo) PL/J model are discussed in the context of current literatures of human and other autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242511     DOI: 10.1038/jid.2009.43

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

1.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

2.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

3.  Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy.

Authors:  Sanjay Anand; Clara Wilson; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Res       Date:  2011-08-01       Impact factor: 12.701

4.  Targeted Ultrasound-Assisted Cancer-Selective Chemical Labeling and Subsequent Cancer Imaging using Click Chemistry.

Authors:  Hua Wang; Marianne Gauthier; Jamie R Kelly; Rita J Miller; Ming Xu; William D O'Brien; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-24       Impact factor: 15.336

Review 5.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

6.  Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.

Authors:  Yangping Wu; Xiangzheng Chen; Xiaojun Ge; Hongwei Xia; Yuxi Wang; Siyuan Su; Wenting Li; Tinghan Yang; Mingtian Wei; Hang Zhang; Lantu Gou; Jiong Li; Xian Jiang; Jinliang Yang
Journal:  J Mol Med (Berl)       Date:  2015-09-18       Impact factor: 4.599

7.  Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.

Authors:  Jinlin Liu; Ning Zhang; Qun Li; Weiwei Zhang; Fang Ke; Qibin Leng; Hong Wang; Jinfei Chen; Honglin Wang
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice.

Authors:  Immanuel Lerner; Eyal Zcharia; Tzahi Neuman; Esther Hermano; Ariel M Rubinstein; Israel Vlodavsky; Michael Elkin
Journal:  Cell Mol Life Sci       Date:  2013-10-30       Impact factor: 9.261

Review 9.  New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors:  Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-07-22       Impact factor: 8.551

10.  Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Liming Mao; Peizeng Yang; Shengping Hou; Fuzhen Li; Aize Kijlstra
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.